DavidW.AndrewsMD

Neurosurgery • Philadelphia, PA

Brain & Spinal Tumor, Skull Base, Stereotactic & Functional Neurosurgery

Jefferson Neurosurgery Associates

Join to view full profile

Dr. Andrews is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Andrews' full profile

Already have an account?

Office
901 Walnut St
Suite 310T
Philadelphia, PA 19107
Phone+1 215-955-7000

Fax+1 215-503-7007

Education & Training

New York Presbyterian Hospital (Cornell Campus)Residency, Neurological Surgery, 1984 - 1989
New York Presbyterian HospitalInternship, Transitional Year, 1983 - 1984
University of Colorado School of Medicine Anschutz Medical CampusClass of 1983

Certifications & Licensure

NJ State Medical License 2012 - 2025
PA State Medical License 1989 - 2024
American Board of Neurological Surgery Neurological Surgery

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2006-2014
Philadelphia Magazine Castle Connolly, 2004-2014
America's Top Doctors for Cancer Castle Connolly, 2005-2013
CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012-2013
Super Doctor SuperDoctors.com
Top MD Consumers Checkbook
Fellow (FACS) American College of Surgeons
Fellow (FAANS) American Association of Neurological Surgeons
Join now to see all

Clinical Trials

Radiation Therapy With or Without Radiosurgery in Treating Patients With Brain Metastases Start of enrollment: 1996 Jan 01
Completed
Phase 3
Pilot Immunotherapy Trial for Recurrent Malignant Gliomas Start of enrollment: 2012 Feb 09
Completed
Phase 1
Phase I Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Start of enrollment: 2012 Nov 09
Completed
Phase 1
Vemurafenib Combined With Whole Brain Radiation Therapy or Radiosurgery in Patients With BRAF Mutation-Positive Melanoma and Brain Metastases
Withdrawn
Phase 1
Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas Start of enrollment: 2015 Jan 30
Completed
Phase 1
Antisense102: Pilot Immunotherapy for Newly Diagnosed Malignant Glioma Start of enrollment: 2015 Sep 01
Completed
Phase 1
Intensity-Modulated Stereotactic Radiation Therapy in Treating Patients With Grade II-IV Glioma Start of enrollment: 2017 Jul 17
Recruiting
Not Applicable
Join now to see all

Publications & Presentations

PubMed

Baseline single institutional retrospective review of body mass index (BMI) as a prognostic indicator in patients with newly diagnosed glioblastoma (GBM).
Louis Cappelli, Adam Uppendahl, Christopher Gardner, Mehak Khan, Allison Kayne
Journal of Clinical Neuroscience. 2024-09-01
Stereotactic radiosurgery in the management of non-small cell lung cancer brain metastases: a prospective study using the NeuroPoint Alliance Stereotactic Radiosurgery...
Giorgos D Michalopoulos, Konstantinos Katsos, Inga S Grills, Ronald E Warnick, James McInerney
Journal of Neurosurgery. 2024-05-01
Correction to: Targeted immunotherapy for glioblastoma involving whole tumor-derived autologous cells in the upfront setting after craniotomy.
Carrie E Andrews, Jenny Zilberberg, Raul Perez-Olle, Mark A Exley, David W Andrews
Journal of Neuro-Oncology. 2024-04-01

Press Mentions

Imvax Charges Ahead with Phase IIb Glioblastoma TrialMarch 29th, 2023
Immunotherapy Implants Turn Brain Tumors Against ThemselvesJune 23rd, 2023

Grant Support

Reducing College Drinking: Testing A Town/Gown CoalitionNational Institute On Alcohol Abuse And Alcoholism2004

Professional Memberships

Congress of Neurological Surgeons - CNS
Member
American Association of Neurological Surgeons - AANS
Fellow
American College of Surgeons - ACS
Member